News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Accium BioSciences, Inc. Takes $3 Million Series A
January 6, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Accium BioSciences, a provider of bioanalytical services with a focus on early-stage drug development, has raised $3 million in a Series A round.
Twitter
LinkedIn
Facebook
Email
Print
Startups
MORE ON THIS TOPIC
IPO tracker
Generate’s IPO Could Reach $425M, Largest Raise Yet
February 24, 2026
·
5 min read
·
Tristan Manalac
Manufacturing
AbbVie Backs Obesity Push With $380M API Production Expansion Project in Illinois
February 24, 2026
·
2 min read
·
Nick Paul Taylor
Executive appointments
Merck Reorganizes Human Health Work Into Two New Units
February 23, 2026
·
1 min read
·
Annalee Armstrong
Weight loss
Novo’s CagriSema Falls to Lilly’s Zepbound in Daring Head-to-Head Test
February 23, 2026
·
4 min read
·
Annalee Armstrong